评估脾脏作为放射治疗危及器官及其与放射性淋巴细胞减少症的关系:一项回顾性研究及文献综述
本研究通过系统文献综述和回顾性研究探讨脾脏照射与淋巴细胞毒性的关系。46例接受放疗的局部晚期胃癌、食管癌和胰腺癌患者纳入研究,勾画脾脏并分析剂量体积参数与淋巴细胞计数。文献综述纳入5项研究共408例患者。单因素和多因素线性回归发现V15(以化疗为控制因素)与最低淋巴细胞计数相关(P=.04),DMAX与最低淋巴细胞计数相关(P=.046)。脾脏平均剂量每增加1 Gy,最低绝对淋巴细胞计数下降1%。结论认为尽管脾脏淋巴细胞减少症剂量体积阈值尚无共识,但所有研究均发现较高的脾脏剂量增加淋巴细胞减少症风险。
要点
- 脾脏V15和最大剂量照射与放化疗期间淋巴细胞减少症相关
- 脾脏平均剂量每增加1 Gy,最低绝对淋巴细胞计数下降1%
- 文献综述中所有研究均发现较高的脾脏剂量增加淋巴细胞减少症风险
核心结论
- 尽管关于淋巴细胞减少症的脾脏剂量体积阈值尚无共识,但所有研究均发现较高的脾脏剂量增加淋巴细胞减少症风险。
- 本研究结果提示脾脏非计划性V15和最大剂量照射与放化疗期间淋巴细胞减少症相关。
研究设计与样本
- 本研究为回顾性研究,纳入46例接受放疗的局部晚期胃癌、食管癌和胰腺癌患者,为每例患者勾画脾脏。
- 系统文献综述检索PubMed、SCOPUS、Cochrane Central Databases和Google Scholar,纳入5项研究共408例患者。
主要发现
- 文献综述关于脾脏非计划性照射与淋巴细胞毒性共纳入5项研究、408例患者。
- 本研究中单因素和多因素线性回归发现V15(以化疗为控制因素)与最低淋巴细胞计数相关(P=.04)。
- 本研究中单因素和多因素线性回归发现DMAX与最低淋巴细胞计数相关(P=.046)。
- 脾脏平均剂量每增加1 Gy,最低绝对淋巴细胞计数下降1%。
关键数值与推荐
- 评估脾脏剂量体积参数包括接受5至40 Gy的体积(以5 Gy递增)、最小剂量、平均剂量和最大剂量。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We conducted a systematic review and a retrospective study to investigate the relationship between spleen irradiation and lymphocyte toxicity. METHODS AND MATERIALS: Forty-six patients diagnosed with locally advanced gastric, esophageal, and pancreatic cancer who underwent radiation therapy were included in this study. The spleen was contoured for each patient. Volumes that received 5 up to 40 Gy (5 Gy increments), minimum, mean, and maximum dose were considered along with lymphocyte count to determine toxicity. Comprehensive and systematic literature searches were performed using PubMed, SCOPUS, Cochrane Central Databases, and Google Scholar. RESULTS: Literature review on spleen unintended irradiation and lymphocyte toxicity resulted in 408 patients from 5 studies. In our study, univariate and multivariate linear regressions found an association between V15 (chemotherapy as controlling factor) and nadir lymphocyte count (P = .04) and between DMAX and nadir lymphocyte count (P = .046). An increase of 1 Gy in mean splenic dose was associated with a 1% decrease in absolute lymphocyte count at nadir. CONCLUSIONS: Although there is no consensus regarding lymphopenia spleen dose volume threshold, all studies found that higher splenic dose increases the risk of lymphopenia. Our study's results suggest that spleen unintentional V15 and maximum dose irradiation were associated with lymphopenia during chemoradiation therapy.
引用
- Alexandru M, Rodica A, Dragos-Eugen G, et al. Assessing the Spleen as an Organ at Risk in Radiation Therapy and Its Relationship With Radiation-Induced Lymphopenia: A Retrospective Study and Literature Review. Adv Radiat Oncol. 2021. PMID: 34934857. doi:10.1016/j.adro.2021.100761
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。